Ezetimibe/rosuvastatin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with ezetimibe/rosuvastatin
V
- valoctocogene roxaparvovec
- Varubi (rolapitant)
- Varubi IV (rolapitant)
- Veklury (remdesivir)
- Velban (vinblastine)
- Velcade (bortezomib)
- Velivet (desogestrel / ethinyl estradiol)
- vemurafenib
- VePesid (etoposide)
- VeraRing (ethinyl estradiol / etonogestrel)
- Vestura (drospirenone / ethinyl estradiol)
- Viberzi (eluxadoline)
- Vida Mia Pain Relief (aspirin/citric acid/sodium bicarbonate)
- Videx (didanosine)
- Videx EC (didanosine)
- Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Vienva (ethinyl estradiol / levonorgestrel)
- Vijoice (alpelisib)
- vinblastine
- Vincasar PFS (vincristine)
- vincristine
- vincristine liposome
- vinorelbine
- Viorele (desogestrel / ethinyl estradiol)
- Viracept (nelfinavir)
- Virtrate-2 (citric acid/sodium citrate)
- Virtrate-3 (citric acid/potassium citrate/sodium citrate)
- Vivitrol (naltrexone)
- Vivjoa (oteseconazole)
- voclosporin
- Volnea (desogestrel / ethinyl estradiol)
- Vonjo (pacritinib)
- Vosevi (sofosbuvir / velpatasvir / voxilaprevir)
- Votrient (pazopanib)
- Voydeya (danicopan)
- VP-Precip (bilberry / evening primrose / flax)
- Vumon (teniposide)
- Vyfemla (ethinyl estradiol / norethindrone)
- VyLibra (ethinyl estradiol / norgestimate)
- Vyndamax (tafamidis)
- Vyndaqel (tafamidis)
- Vytorin (ezetimibe / simvastatin)
More about ezetimibe / rosuvastatin
- ezetimibe/rosuvastatin consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Imprints, shape & color data
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antihyperlipidemic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.